Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines

Article

关键词: ENDOTHELIAL PROGENITOR CELLS;    GROWTH-FACTOR;    INFARCTED MYOCARDIUM;    STROMAL CELLS;    EXPRESSION;    NEOVASCULARIZATION;    TRANSPLANTATION;    OVEREXPRESSION;    VASCULOGENESIS;    RECEPTORS;   

DOI  :  10.1161/hc3501.093817

来源: SCIE

【 摘 要 】

Background-Bone marrow implantation (BMT) was shown to enhance angiogenesis in a rat ischemic heart modal. This preclinical study using a swine model was designed to test the safety and therapeutic effectiveness of BMI. Methods and Results-BM-derived mononuclear cells (BM-MNCs) were injected into a zone, made ischemic by coronary artery ligation. Three weeks after BMI, regional blood flow and capillary densities were significantly higher (4.6- and 2.8-fold, respectively), and cardiac function was improved. Angiography revealed that there was a marked increase (5.7-fold) in number of visible collateral vessels. Implantation of porcine coronary microvascular endothelial cells (CMECs) did not cause any significant increase in capillary densities. Labeled BM-MNCs were incorporated into approximate to 31% of neocapillaries and corresponded to approximate to8.7% of macrophages but did not actively survive as myoblasts or fibroblasts. There was no bone formation by osteoblasts or malignant ventricular arrhythmia. Time-dependent changes in plasma levels for cardiac enzymes (troponin I and creatine kinase-MB) did not differ between the BMI, CMEC, and medium-alone implantation groups. BM-MNCs contained 16% of endothelial-lineage calls and expressed basic fibroblast growth factor much greater than vascular endothelial growth factor>angiopoiatin 1 mRNAs, and their cardiac levels were significantly upregulated by BMI. Cardiac interleukin-1 beta and tumor necrosis factor-alpha mRNA expression were also induced by BMI but not by CMEC implantation. BM-MNCs were actively differentiated to endothelial cells in vitro and formed network structure with human umbilical vein endothelial calls. Conclusions-BMI may constitute a novel safety strategy for achieving optimal therapeutic angiogenesis by the natural ability of the BM cells to secrete potent angiogenic ligands and cytokines as well as to be incorporated into foci of neovascularization.

【 授权许可】

Free